APA

United States, . (2010). Challenges to FDA's ability to monitor and inspect foreign clinical trials. [Washington, D.C.]: Department of Health and Human Services, Office of Inspector General.

Chicago

United States, . 2010. Challenges to FDA's ability to monitor and inspect foreign clinical trials. [Washington, D.C.]: Department of Health and Human Services, Office of Inspector General.

Harvard

United States, . (2010). Challenges to FDA's ability to monitor and inspect foreign clinical trials. [Washington, D.C.]: Department of Health and Human Services, Office of Inspector General.

MLA

United States, . Challenges to FDA's ability to monitor and inspect foreign clinical trials. [Washington, D.C.]: Department of Health and Human Services, Office of Inspector General. 2010.